Gastroenterology Clinics of North America 2003: Vol 32 Index

49 Pages·2003·6.8 MB·English

GASTROENTEROLOGY
CLINICS OF
S NORTH AMERICA
Gastroenterol Clin N Am
32 (2003) 1311-1359
Cumulative Index 2003
Volume 32
March GASTROINTESTINAL DISORDERS DURING PREGNANCY, pages 1-462
June FUNCTIONAL DISORDERS OF THE GASTROINTESTINAL TRACT,
pages 463-762
September PEDIATRIC GASTROENTEROLOGY, pages 763-1034
September PHARMACOLOGICAL PRINCIPLES GOVERNING THE USE OF
PROTON PUMP INHIBITORS: TAILORING THERAPY TO IMPROVE
GERD OUTCOMES, pages S1-S49
December GASTROENTEROLOGIC EMERGENCIES: DIAGNOSIS AND MAN-
AGEMENT, pages 1035-1359
Note: Page numbers of article titles are in bold face type; the letter ““S” before a page number
indicates the Supplement issue.
A ectopic, 10-13
Abdomen endoscopy in, 8-9
distention of extraabdominal causes of. 42
in intestinal ischemia, 1129 heterotopic, 13
in small intestinal obstruction, idiopathic, 42-43
1230 imaging in, 8
pressure in, in pregnancy, in adnexal disorders, 15-17
gastroesophageal reflux disease in appendicitis, 18-20
and, 239-240 in bacteriuria, 37-38
in Budd-Chiari syndrome, 35-36
Abdominal compartment syndrome, in in cholecystitis, 28-29
pancreatitis, 1179-1180 in choledochal cysts and
Abdominal migraine, cyclic vomiting neoplasms, 30
syndrome and, 996, 1003-1005, si choledocholithiasis, ae
1009-1010 in cholelithiasis, 28-29
in cystitis, 37-38
Abdominal pain in diaphragmatic hernia, 23-24
in cholangitis, 1155 in drug toxicity, 42
in cholecystitis, 1146-1147 in eclampsia, 31-33
in colonic perforation, 1302-1303 in endocrinologic disease, 41
in cyclic vomiting syndrome, 996, 998 in endometriosis, 17
in diabetes mellitus, 623 in fatty liver, 34-35
in eosinophilic esophagitis, 950 in gastroesophageal reflux
in HELLP syndrome, 1215 disease, 20-22
in inflammatory bowel disease, 967 in gastrointestinal disorders,
in intestinal ischemia, 1128, 1137 18-27
in mitochondrial disorders, 793 in genitourinary cancer, 39
in pancreatitis, 1171-1173 in gynecologic disorders, 3, 15-18
in preeclampsia, 1214 in HELLP syndrome, 32-33, 417
in pregnancy, 1-57 in hematologic disease, 40-41
abdominal, 13 in infections, 41-42
differential diagnosis of, 1-7, 183 in inflammatory bowel disease,
diffuse, 1 24-26
0889-8553/03/$ - see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/S0889-8553(03)00109-2
1312 Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Abdominal (continued) Abuse, functional gastrointestinal disorders
in intestinal obstruction, 22—23 and, 482-484, 493-494
in intestinal pseudo-obstruction,
Acalculous cholecystitis, acute, 1152-1153
24
irritable bowel syndrome, Accommodation, impaired, in functional
26-27, 387-388, 403 dyspepsia, 576-577
kidney disorders, 37-39
leiomyoma, 17-18 Acetate breath test, in motility testing, 743
liver disease, 30-37 Acetylcholine, in gastric acid secretion, $37
nausea and vomiting, 212
obstetric disorders, 3, 10-15 Achalasia, dysphagia in, 563, 566-567
pancreatitis, 27-28 Acid ingestion, esophageal damage in,
pancreatobiliary disease, 1035-1038
27-30
in pelvic inflammatory disease, 17 Acid suppressive therapy. See also specific
in peptic ulcer disease, 20-22, 265 drugs.
in placenta previa, 14-15 for peptic ulcer bleeding, S$14-S18
placental abruption, 14 for stress ulcer bleeding, S19-S21
porphyria, 36-37
Acidosis, lactic. See Lactic acidosis.
preeclampsia, 31-33
premature labor, 15 Aciphex. See Rabeprazole.
spontaneous abortion, 13-14
Acquired immunodeficiency syndrome. See
systemic diseases, 40-42
Human immunodeficiency virus
trophoblastic proliferations, 15
infection.
tubo-ovarian abscess, 17
upper gastrointestinal Acupuncture
bleeding, 22 for irritable bowel syndrome, 523
urinary tract disorders, 37-39 for sphincter of Oddi dysfunction, 610
uterine rupture, 18
in vascular diseases, 40-41 Acute colonic pseudo-obstruction
lower left quadrant, 3 (Ogilvie’s syndrome), 1233-1242
lower right quadrant, 3 clinical features of, 1235, 1237
neurophysiology of, 4-5 diagnosis of, 1237
parietal, 5 etiology of, 1235-1236
physiologic effects in, 7-8 in pregnancy, 24, 191-192
psychologic factors in, 5 pathogenesis of, 1235
referred, 5 treatment of, 1237-1242
team approach to, 9-10 Acute fatty liver of pregnancy. See Fatty
upper left quadrant, 2 liver of pregnancy.
upper right quadrant, 2
visceral, 4—5 Acyclovir, for herpesvirus infections, in
in small intestinal obstruction, 1230 pregnancy, 1221
in sphincter of Oddi dysfunction, Acylearnitine profile, in mitochondrial
602-604 disorders, 810
Abdominal pregnancy, pain in, 13 Addison’s disease, in pregnancy, 41
Abortion, spontaneous Adenocarcinoma, of esophagus, S6
in portal hypertension, 422
pain in, 13-14 Adenoma, of liver, in pregnancy, 36
Abruption, placental, pain in, 14 S-Adenosyl methionine, for intrahepatic
cholestasis of pregnancy, 413
Abscess(es)
in Crohn’s disease, 1275-1278 Adhesions, small intestinal obstruction in,
in esophageal perforation, 1039 1230
in pregnancy
Adnexal disorders, pain in, in pregnancy,
liver, 36
15-17
tubo-ovarian, 17
pancreatic, 1179 Adrenalin, for peptic ulcer bleeding,
$13-S14
Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359 1313
Adult respiratory distress syndrome, in Ampicillin, for endoscopy, 131, 135-136
fulminant hepatic failure, 1199-1200
Anemia
Adynamic ileus, in pregnancy, 24 in Pearson marrow-pancreas
syndrome, 777, 801-802
Aganglionic megacolon. See Hirschsprung
in pregnancy
disease.
in colorectal cancer, 350, 360
AIDS. See Human immunodeficiency virus treatment of, 89
infection. in Shwachman-Diamond syndrome,
774
Airway, edema of, in caustic ingestion, 1037 iron deficiency, in celiac disease,
Alagille syndrome, 866-871 931-932
clinical manifestations of, 868-870 Anesthesia
description of, 866
for delivery, aspiration in, 254-256
diagnosis of, 870-871
for surgery, in pregnancy, 184
genetics of, 866-868
prognosis for, 871 Aneurysm, splenic artery, in pregnancy, 40,
treatment of, 871 192, 424
Alkaline ingestion, esophageal damage in, Angina, versus noncardiac chest pain,
1035-1038 531-533
Allergy, food, eosinophilic esophagitis and, Angiodysplasia, bleeding in, 1108,
946, 948, 950, 956-959 1113-1116
Allodynia, definition of, 734-735 Angiography
in angiodysplasia, 1115
Alosetron in arterial pseudoaneurysm, in
for functional dyspepsia, 588
pancreatitis, 1188-1189
for functional gastrointestinal in intestinal ischemia, 1137, 1139
disorders, 721-722 in lower gastrointestinal bleeding,
for irritable bowel syndrome, 519 1111-1112
Alpers—Huttenlocher syndrome, 798 magnetic resonance, in intestinal
ischemia, 1130-1131
Alpha>-adrenoreceptor agonists, for
functional gastrointestinal disorders, Angioma, bleeding from, electrocoagulation
723-724 for, 1066
Alpha-fetoprotein, elevated, in Anismus. See Constipation, dyssynergic.
hemochromatosis, 884 Anorectal manometry, in constipation, 662,
Alternative medicine 666-668
for functional gastrointestinal Anorexia, in chronic diarrhea and intestinal
disorders, 725 pseudo-obstruction, 802
for irritable bowel syndrome, 402,
522-523 Antacids
for GERD, 540-541, S40
Amino acids, analysis of, in mitochondrial in anesthesia, 255
disorders, 810 in pregnancy, 21, 243-244
Aminoacidemias and aminoacidurias, for peptic ulcer disease, 275-276
pancreatitis in, 773 Anti-inflammatory drugs, for eosinophilic
5-Aminosalicylic acid, for inflammatory esophagitis, 953-956
bowel disease, 329
Antibiotics
Amitriptyline after portoenterostomy, 901
for cyclic vomiting syndrome, for appendicitis, 187
1006-1007 for cholangitis, 1156-1157
for dysphagia, 569 for cholecystitis, 1150
for chronic intestinal
Amoxicillin pseudo-obstruction, 643
for Helicobacter pylori infections, $42 for diarrhea, 319-320, 1259
for peptic ulcer disease, 278, 285 for endoscopy, 131, 135-137
1314 Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Antibiotics (continued) Aortography, in intestinal ischemia,
for esophageal perforation, 1041-1042 1135-1136
for inflammatory bowel disease,
Apoprotein C-11 defects, pancreatitis in,
329-330
772-773
for intestinal ischemia, 1131
for pancreatitis, 1178 Appendicitis, in pregnancy, 18-20,
for peptic ulcer disease, 278, 184-187
285-288 versus peptic ulcer disease, 269
for Vibrio infections, 1252
Argon plasma coagulation, for upper
Antibody(ies) gastrointestinal bleeding, 1065
endomysial, in celiac disease, 934-935
in chronic intestinal Arterial pseudoaneurysm, in pancreatitis,
pseudo-obstruction, 636, 638 1188-1189
transglutaminase, in celiac disease, Arthritis, in inflammatory bowel disease,
929-930, 935 969-970
Anticholinergic agents Ascending cholangitis, in polycystic kidney
for functional gastrointestinal disease with hepatic fibrosis,
disorders, 714-715 863-864
for irritable bowel syndrome,
398-399 Ascites, in pancreatitis, 1179-1180, 1183,
1185
Anticoagulants
for inflammatory bowel disease, 1282 Ascorbic acid (vitamin C), in pregnancy
for intestinal ischemia, 1137, 1140 deficiency of, 66, 70
excess of, 66, 70
Antidepressants requirements of, 62, 70-71
for cyclic vomiting syndrome,
1006-1007 Asimadoline, for functional gastrointestinal
for dysphagia, 569 disorders, 723
for functional dyspepsia, 587 Aspiration
for functional gastrointestinal nasogastric, for upper gastrointestinal
disorders, 718-720 bleeding, 1055
for irritable bowel syndrome, 399-400, pulmonary
520 in anesthesia, 254-256
for noncardiac chest pain, 542-543 in tube feeding, 91
Antidiarrheal agents in variceal bleeding, 1084
for acute severe diarrhea, 1259-1260 Aspirin, Reye’s syndrome and, 804-805
for irritable bowel syndrome, 516
Atherosclerosis, intestinal ischemia in,
Antiemetic agents 1135-1137
for functional gastrointestinal
disorders, 725 Atropine, for functional gastrointestinal
for gastroparesis, 631-632 disorders, 714
Antihistamines, for nausea and vomiting, Attapulgite, for diarrhea, 1260
220
Autoimmune disorders
Antioxidants, for hemochromatosis, 885 biliary atresia as, 895-896
celiac disease in, 934
Antispasmodics hepatitis as, in pregnancy, 1223
for functional gastrointestinal
disorders, 714-716 Autonomic nervous system
for irritable bowel syndrome, 398-399, dysfunction of
516-518 in chronic intestinal
pseudo-obstruction, 638
Antroduodenal manometry, for in congenital central
gastroparesis, 625-626
hypoventilation syndrome,
Anxiety disorders, functional 823
gastrointestinal disorders and, 481 in cyclic vomiting syndrome,
1005, 1011
Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
in diabetes mellitus, gastroparesis Batteries, button-type, lodging in
in, 622 esophagus, 1049
in functional dyspepsia, 581
function of, 469-470 BCSIL gene mutations, siderosis in, 880
Beano, for irritable bowel syndrome,
Autosomal dominant progressive external
ophthalmoplegia, 794 400-401
Behavioral disorders, constipation as,
Avoidance therapy, for eosinophilic
662-663
esophagitis, 956-959
Axid. See Nizatidine. Bendectin, for nausea and vomiting, 217
Bernstein test, in noncardiac chest pain, 538
Ayurvedic herbal medicine, for irritable
bowel syndrome, 523 Beta-blockers
for portal hypertensive gastropathy.
Azathioprine, for inflammatory bowel
1096, 1098
disease, 330-331
for variceal bleeding, 1082, 1091-1092
Bethanechol, for functional gastrointestinal
B disorders, 711-712
Baclofen, for functional gastrointestinal
Bezoars, small intestinal obstruction from,
disorders, 713
1232
Bacteriuria, in pregnancy, 37-38
Bifidobacterium, for irritable bowel”
Balloon dilation, for dysphagia, 562-563. syndrome, 514
566-567
Bile
Balloon expulsion test, in constipation, 668 analysis of, in cholestasis, 847
formation and transport of, disorders
Balloon-occluded retrograde transvenous
of, 839-855, 912
obliteration, of gastric varices, 1095 benign recurrent intrahepatic
Balloon tamponade, for variceal bleeding, cholestasis, 843
1087-1088 cryptogenic cirrhosis and
multidrug resistant type 3
Band ligation deficiency, 846
for bleeding, in diverticulosis, 1113 diagnosis of, 847-849
for small intestinal perforation, 1299 Dubin-Johnson syndrome,
for upper gastrointestinal bleeding, 846-847
1067-1068 gallstone disease and multidrug
for variceal bleeding, 1086, 1095 resistant type 3 deficiency,
Bardet-Bied| syndrome, Hirschsprung 845-846
disease in, 824 intrahepatic cholestasis of
pregnancy and multidrug
Bariatric procedures, in pregnancy, resistant type 3 deficiency,
103-104 844-845
Barium studies physiologic considerations in,
in chronic intestinal 839-841
pseudo-obstruction, 639 progressive familial intrahepatic
in constipation, 666 cholestasis, 841-844, 846
in dysphagia, 556-557, 559 treatment of, 849-851
physiology of, 839-841
in esophageal perforation, 1041
in gastroesophageal reflux disease, toxicity of, mitochondrial damage in,
807-808
534
in noncardiac chest pain, 534 Bile acids, measurement of, in intrahepatic
Barostat cholestasis of pregnancy, 412
in motility testing, 740-741 Bile ducts
in sensation testing, 736-737 disorders of, 857-875. See also Biliary
Barrett’s esophagus, cancer risk in, S6 atresia.
after liver transplantation,
Basal energy expenditure, in pregnancy, 86 918-919
1316 Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Bile ducts (continued) in chronic intestinal
cystic, 858-865 pseudo-obstruction, 641-642
embryologic considerations in, liver
857-858 in biliary atresia, 898-899
paucity, 865-871 in cholestasis, 847-849
perforation of, 1200 in congenital hepatic fibrosis, 863
in fulminant hepatic failure, 1203
Biliary atresia, 891-907
small intestine, in celiac disease, 934
anatomy of, 896-897
classification of. 896-897 Biotin, requirements of, in pregnancy, 61
epidemiology of, 891
Bisacodyl, for constipation, 313
etiology of, 892-896
evaluation of, 897-899 Bismuth subgallate, for peptic ulcer disease,
fetal, 892 278
genetics of, 895
histopathology of, 896-897 Bismuth subsalicylate
historical background of, 891 for diarrhea, 318, 1260
perinatal, 892 for peptic ulcer disease, 286
postnatal, 892 Bisphosphonates, for osteopenia, in
treatment of, 891-892, 900-902 inflammatory bowel disease, 979
Biliary colic Bladder, infections of, in pregnancy, 37-38
in cholecystitis, 1146
in gallbladder dysmotility, 612-613 Bleeding
in pregnancy, 28-29, 150-156 disorders of. See Coagulopathy.
from ulcers, S11-S23
Biliary pain, classification of, 603-604 peptic, S11-S18
Biliary tract. See also Bile ducts; stress, $18-S21
Gallbladder. in liver transplantation, 918
dysfunction of. See also Cholecystitis: in pancreatitis, 1180, 1184, 1188-1189
Cholangitis. in pregnancy
in inflammatory bowel disease, ectopic, 12
970 endoscopy for, 142-143
in pregnancy, 29-30, 150-156, in liver rupture, 33-34, 189-190
187-189 in peptic ulcer disease, 291-292
dysmorphogenesis of, biliary atresia in placental disorders, 14-15
in, 894 in portal hypertension, 423-427
endoscopic drainage of, for upper gastrointestinal, 22,
cholangitis, 1157-1158 142-143
fistula of, in pancreatitis, 1180 intracranial, in Alagille syndrome,
functional disorders of. See also 869-870
Sphincter of Oddi, liver, in pregnancy, 1218
dysfunction of. lower gastrointestinal, 1107-1125
gallbladder motility disorders, definition of, 1107
612-613 diagnostic evaluation of,
obstruction of 1110-1112
cholangitis in, 154 etiology of, 1107-1108
in pancreatitis, 1186-1187 in angiodysplasia, 1108,
partial diversion of, with ileal 1113-1116
exclusion, for cholestasis, 850 in diverticulosis, 1108,
1112-1113
Biofeedback training hemorrhoids, 1116
for constipation, 673 infectious colitis, 1118-1119
for fecal incontinence, 691-694 inflammatory bowel disease,
Biologic agents, for inflammatory bowel 1117, 1275
disease, 332 intestinal ischemia, 1128-1129
ischemia, 1116-1117
Biopsy neoplasia, 1108, 1119
esophagus, in eosinophilic esophagitis, radiation colitis, 1119
951 stercoral ulcers, 1119
Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359 1317
initial evaluation and Brain-gut axis, disturbances of, 466-471
resuscitation in, 1107, 1109 autonomic nervous system, 469-470
mortality in, 1107-1108, combined sensory-motor, 466-467
1119-1120 enteric nervous system, 468-469
NSAID-induced, 1116 motor, 466
outcomes of, 1119-1120 peripheral sensory pathways, 470-471
postpolypectomy, 1117-1118 psychosocial influences on, 467,
postpartum, in portal hypertension, 487-489
424
Breastfeeding
upper gastrointestinal, 1053-1078
GERD drugs during, 256-257
clinical presentation of,
HIV transmission in, 441
1054-1055
inflammatory bowel disease drugs
diagnosis of, 1056-1060
during, 333-334
epidemiology of, 1053
etiology of, 1053-1054 Breath testing
in portal hypertension. See Portal in motility testing, 743-744
hypertension. stable isotope, in gastroparesis,
initial evaluation of, 1055-1056 624-625
prognosis of, 1055-1056
treatment of BRESEK syndrome, Hirschsprung disease
endoscopic, 1060-1069 in, 824
medical, 1070-1071 Bristol Stool Scale, in constipation, 663-664
triage in, 1060
variceal. See Varices, BSEP gene mutations, in progressive
gastroesophageal, bleeding familial intrahepatic cholestasis, type
from. II, 844
Blood loss, in pregnancy, hypovolemia Budd-Chiari syndrome, in pregnancy,
correction in, 88-89 35-36, 224, 1222
Body mass index, in pregnancy, 82 Burns, of esophagus, in caustic ingestion,
1035-1038
Boerhaave’s syndrome, 1039-1040
Buspirone
Bone marrow failure for functional dyspepsia, 588
in Pearson marrow-pancreas for functional gastrointestinal
syndrome, 801-802 disorders, 717
in Shwachman-Diamond syndrome,
775-777 Butterfly vertebrae, in Alagille syndrome,
869
Bone mineral density, reduced
in celiac disease, 933 Byler disease (progressive familial
in inflammatory bowel disease, intrahepatic cholestasis), 773, 842
977-979
Botulinum toxin C
for esophageal sphincters
Calciferol (vitamin D), in pregnancy
in dysphagia, 566
deficiency of, 66, 72-73
in noncardiac chest pain, 542
for sphincter of Oddi dysfunction, 610 excess of, 66, 72
requirements of, 63, 72-73
Bougienage, in dysphagia, 562-563
Calcium
Bradygastria, in pregnancy, 206-209 deficiency of, in inflammatory bowel
disease, 978
Brain
in pregnancy
activation of, in functional
deficiency of, 66, 75-76
gastrointestinal disorders,
excess of, 66
471-472
requirements of, 63, 75-76
edema of, in fulminant hepatic failure,
1198-1199 Calcium channel blockers
vascular anomalies in, in Alagille for functional gastrointestinal
syndrome, 869-870 disorders, 715
1318 Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Calcium channel (continued) clinical manifestations of,
for irritable bowel syndrome, 398-399 930-933
for sphincter of Oddi dysfunction, definition of, 927
610 diagnosis of, 935-936
differential diagnosis of, 936
Calculous cholecystitis, acute, 1145-1151
diseases associated with, 934
Campylobacter jejuni infections, diarrhea in, epidemiology of, 927-928
1253 genetics of, 928
histopathology of, 936
Cancer in pregnancy
acute colonic pseudo-obstruction in, hyperemesis gravidarum in,
1236
224-225
esophageal, 555, S6
nutrition in, 101-102
in celiac disease, 936-937 pathogenesis of, 929-930
in multiple endocrine neoplasia 2, prevention of, 937-938
823-824 prognosis for, 936-937
in pregnancy serologic markers of, 934-935
gastrointestinal, 193-194. See treatment of, 937-938
also Colorectal cancer.
gastric, 296-297 Central nervous system, dysfunction of,
versus peptic ulcer disease, irritable bowel syndrome related to,
269-270 390-391
genitourinary, 39
Cereulide, mitochondrial disorders from,
ovarian, 15-16
806
small intestinal, obstruction in, 1232
Charcot’s triad, in cholangitis, 1155
Carbamazepine, for cyclic vomiting
syndrome, 1007 Chelation therapy, for hemochromatosis,
885
Carbon dioxide, stable isotope of, in breath
testing, for gastroparesis, 624-625 Chemotherapy, for colorectal cancer,
362-366
Carcinoembryonic antigen, in colorectal
cancer, 355 Chest pain, noncardiac, 529-550
definition of, 529
Cardiovascular disorders
evaluation of, 531-540
acute colonic pseudo-obstruction in,
cardiologist role in, 531-533
1236
esophageal manometry in,
fulminant hepatic failure and, 1197,
536-538
1199
in gastroesophageal reflux
in Alagille syndrome, 869-870
disease, 533-536
Cardiovascular system, changes in, in provocative tests in, 538
pregnancy, 18!—182, 418-420 psychologic evaluation in,
538-539
Caroli disease, 859
in diabetes mellitus, 623
Cascara, for constipation, 313 in esophageal foreign body, 1044
in esophageal perforation, 1039
Cataract, in inflammatory bowel disease, pathophysiology of, 530-531
1283 treatment of, 540-545, 717-724
Caustic ingestion, esophageal damage in, Chinese herbal medicine, for irritable bowel
1035-1038, 1049 syndrome, 523
Cecum, volvulus of, 1233-1234 Chlorpromazine, for cyclic vomiting
Celiac axis syndrome, 1007
anatomy of, 1127-1128 Cholangiography
ischemia of. See Intestinal ischemia. in biliary atresia, 899
Celiac disease, 927-943 in cholestasis, 847
atypical presentation of, 931 Cholangiopancreatography, magnetic
classical presentation of, 930 resonance, in cholangitis, 1156
Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Cholangitis pancreatitis in, 1170-1173
acute, 1154-1161 small intestinal obstruction from, 1232
clinical presentation of,
Cholera, diarrhea in, 1252
1155-1156
diagnosis of, 1155-1156 Choleresis, after portoenterostomy, 901
pathophysiology of,
1154-1155 Cholescintigraphy
treatment of, 1156-1161 in gallbladder dysmotility, 612-613
after portoenterostomy, 901 in sphincter of Oddi dysfunction,
ascending 608-610
clinical algorithm for, 1160 Cholestasis
in polycystic kidney disease with benign recurrent intrahepatic, 843
hepatic fibrosis, 863-864 diagnosis of, 847-849
sclerosing, in inflammatory bowel in Alagille syndrome, 868
disease, 970, 1283-1284 in biliary atresia, 892
Cholecystectomy in cryptogenic cirrhosis, multidrug
for cholangitis, 1159-1161 resistant type 3 deficiency with,
for cholecystitis, 1150-1151, 1153 846
for gallbladder dysmotility, 613 in Dubin-Johnson syndrome, 846-847
for gallstone pancreatitis, 1173 in gallstone disease, multidrug
in pregnancy, 150-156, 188-189 resistant type 3 deficiency with,
pain after. See Sphincter of Oddi, 845-846
dysfunction of. in mitochondrial DNA depletion
syndrome, 799
Cholecystitis in Navajo neurohepatopathy,
acalculous, acute, 1152-1153 803-804
calculous, acute, 1145-1151 in neonatal liver failure, 797
clinical presentation of, intrahepatic, of pregnancy, 409-414,
1146-1147 1218-1219
complications of, 1151 multidrug resistant type 3
diagnosis of, 1147-1149 deficiency with, 844-845
natural history of, 1146 physiologic considerations in,
outcomes of, 1151 839-84]
pathophysiology of, 1146 progressive familial intrahepatic,
treatment of, 1149-1151 841-842
in pregnancy, 28-29 type | (Byler’s disease), 773, 842
versus peptic ulcer disease, 269 type Il, 843-844
type III, 844
Cholecystokinin
type IV, 846
antagonists of, for gastroparesis, 634
treatment of, 849-851
in sphincter of Oddi function, 601
Cholesterol
Cholecystotomy, percutaneous, for
deficiency of, in progressive familial
cholecystitis, 1151, 1153
intrahepatic cholestasis, type I,
Choledochal cysts 842
biliary atresia and, 894 elevated, in Alagille syndrome, 868
in pregnancy, 30
Cholestyramine
Choledocholithiasis, 1147 for diarrhea, 398
cholangitis in, 1155 for intrahepatic cholestasis of
in pregnancy, 29-30, 150-156 pregnancy, 413, 1219
for irritable bowel syndrome, 516
Choledochotomy, for cholangitis, 1158
Choline, requirements of, in pregnancy, 61
Cholelithiasis
cholangitis in. See Cholangitis. Cholinergic agents, for functional
in cholecystitis, 1146 gastrointestinal disorders, 711-713
in pregnancy, 28-29, 150-156,
Choriocarcinoma
187-189, 1222
hyperemesis gravidarum in, 222-223
multidrug resistant type 3 deficiency
pain in, 15
with, 845-846
1320 Cumulative Index | Gastroenterol Clin N Am 32 (2003) 1311-1359
Chromium, in pregnancy Citalopram, for functional gastrointestinal
deficiency of, 67, 78 disorders, 720
excess of, 78-79
Citrullinemia, pancreatitis in, 773
requirements of, 63, 78-79
CJ-11,974, for functional gastrointestinal
Chromosomal abnormalities, in
disorders, 724
Hirschsprung disease, 821-825
Clarithromycin
Chronic intestinal pseudo-obstruction,
for functional gastrointestinal
636-647
disorders, 711
causes of, 636-637
for peptic ulcer disease, 278, 285-286
classification of, 636-637
clinical manifestations of, 636, 638 Clichy criteria, for hepatic failure prognosis,
diagnosis of, 638-642 1202
in pediatric patients, 636, 644-647
treatment of, 642-644 Clidinium bromide, for irritable bowel
syndrome, 518
Chylomicronemia, in lipoprotein lipase
defects, pancreatitis in, 772-773 Clips
for colonic perforation, 1304
Cilansetron, for irritable bowel syndrome, for diverticular bleeding, 1113
519 for gastric perforation, 1293
for small intestinal perforation,
Cimetidine
1298-1299
for GERD, S40-S41
for upper gastrointestinal bleeding,
in anesthesia, 255
1067-1068
in pregnancy, 244, 246-2
for peptic ulcer disease, 277, Clonidine
for stress ulcers, $19-S20 for functional dyspepsia, 588
mechanism of action of, $27 for functional gastrointestinal
disorders, 713, 717, 723-724
Cimetropium, for functional
gastrointestinal disorders, 714 Clostridium difficile infections, diarrhea in,
1254
Cineradiography, in dysphagia, 556
Coagulation therapy, for peptic ulcer
Ciprofloxacin
bleeding, S13-S14
for chronic intestinal
pseudo-obstruction, 643 Coagulopathy
for inflammatory bowel disease, in fulminant hepatic failure.
329-330 1200-1201
in HELLP syndrome, 1216
Cirrhosis
cryptogenic, multidrug in inflammatory bowel disease,
1281-1282
resistance-associated protein
in liver transplantation, 918
defects with, 846
in inflammatory bowel disease, 970 in lower gastrointestinal bleeding, 1110
in portal hypertension, 1083
in pregnancy, portal hypertension in,
418-427 Cobalamin (vitamin B,>), requirements of,
in progressive familial intrahepatic in pregnancy, 62
cholestasis, type I, 842
portal hypertension in, 418-427, 1080, Codeine, for diarrhea, 328
1084 Cognitive-behavioral therapy
Cisapride for functional gastrointestinal
for chronic intestinal disorders, 495
pseudo-obstruction, 642 for irritable bowel syndrome, 521
for cyclic vomiting syndrome, 1007 Cognitive therapy, for irritable bowel
for functional dyspepsia, 587-588 syndrome, 402
for functional gastrointestinal
disorders, 708 Colchicine, for constipation, 672
for gastroparesis, 630-631, 634 Colectomy
for GERD, 244, 250-251 for constipation, 674